The ciprofloxacin hydrochloride market, valued at $5.2 billion in 2023, is projected to reach $8.3 billion by 2032, driven by rising bacterial infections and the need for effective antimicrobial treatments, with a CAGR of 5.40%. Rising Bacterial Infections:
The increasing prevalence of bacterial infections worldwide fuels the demand for effective antibiotics like ciprofloxacin.